{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:25:49Z","timestamp":1783041949143,"version":"3.54.6"},"reference-count":121,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.thromres.2025.109506","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T22:19:39Z","timestamp":1760393979000},"page":"109506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia"],"prefix":"10.1016","volume":"256","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6501-5959","authenticated-orcid":false,"given":"Mohammad Reza","family":"Moghaddasnejad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1171-7918","authenticated-orcid":false,"given":"Negar Sadat","family":"Sherafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-5594","authenticated-orcid":false,"given":"Najmaldin","family":"Saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9270","key":"10.1016\/j.thromres.2025.109506_bb0005","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.thromres.2025.109506_bb0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1160\/TH14-02-0146","article-title":"Immune functions of platelets","volume":"112","author":"Duerschmied","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2025.109506_bb0015","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1111\/jth.12730","article-title":"Platelets in inflammation and immunity","volume":"12","author":"Herter","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0020","article-title":"Phenotypic and functional diversities of myeloid-derived suppressor cells in autoimmune diseases","volume":"2018","author":"Ma","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/bjh.19079","article-title":"The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia","volume":"203","author":"Yazdanbakhsh","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.thromres.2025.109506_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250345","article-title":"Myeloid-derived suppressor cells in the therapy of autoimmune diseases","volume":"53","author":"Beki\u0107","year":"2023","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0035","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1538-7836.2008.03161.x","article-title":"Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura","volume":"7","author":"Kuwana","year":"2009","journal-title":"J. Thromb. Haemost."},{"issue":"45","key":"10.1016\/j.thromres.2025.109506_bb0040","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1808217115","article-title":"Akt-mediated platelet apoptosis and its therapeutic implications in immune thrombocytopenia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0045","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1038\/ncomms8737","article-title":"Desialylation is a mechanism of fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia","volume":"6","author":"Li","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.thromres.2025.109506_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036936","article-title":"Recent advances in the management of immune thrombocytopenic purpura (ITP): a comprehensive review","volume":"103","author":"Madkhali","year":"2024","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.thromres.2025.109506_bb0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0060","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/421927","article-title":"The role and potential therapeutic application of myeloid-derived suppressor cells in Allo-and autoimmunity","volume":"2015","author":"Zhang","year":"2015","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0065","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12026-023-09421-0","article-title":"Diverse functions of myeloid-derived suppressor cells in autoimmune diseases","volume":"72","author":"Xiong","year":"2024","journal-title":"Immunol. Res."},{"issue":"8","key":"10.1016\/j.thromres.2025.109506_bb0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1586\/1744666X.2015.1052794","article-title":"Myeloid-derived suppressor cells in immunity and autoimmunity","volume":"11","author":"Yang","year":"2015","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.thromres.2025.109506_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40364-020-00207-2","article-title":"Role of platelet biomarkers in inflammatory response","volume":"8","author":"Chen","year":"2020","journal-title":"Biomark. Res."},{"issue":"18","key":"10.1016\/j.thromres.2025.109506_bb0080","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood-2013-11-462432","article-title":"Emerging roles for platelets as immune and inflammatory cells","volume":"123","author":"Morrell","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1182\/blood.2023022738","article-title":"Platelet-derived TGF-\u03b21 induces functional reprogramming of myeloid-derived suppressor cells in immune thrombocytopenia","volume":"144","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109506_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1021612","article-title":"Myeloid-derived suppressor cell: a crucial player in autoimmune diseases","volume":"13","author":"Xu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2025.109506_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104300","article-title":"Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases","volume":"362","author":"Zhang","year":"2021","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.5411\/wji.v4.i1.26","article-title":"Role of myeloid-derived suppressor cells in autoimmune disease","volume":"4","author":"Crook","year":"2014","journal-title":"World Journal of Immunology."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0105","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/s41598-019-40285-3","article-title":"Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells","volume":"9","author":"Goulart","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.thromres.2025.109506_bb0110","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.3390\/ijms21103599","article-title":"Understanding the differentiation, expansion, recruitment and suppressive activities of myeloid-derived suppressor cells in cancers","volume":"21","author":"Lim","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1158\/0008-5472.CAN-17-0348","article-title":"CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions","volume":"78","author":"Blattner","year":"2018","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.thromres.2025.109506_bb0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","article-title":"Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity","volume":"21","author":"Veglia","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","article-title":"Myeloid-derived suppressor cells","volume":"5","author":"Gabrilovich","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"10","key":"10.1016\/j.thromres.2025.109506_bb0140","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.humimm.2021.06.008","article-title":"Myeloid-derived suppressor cells: important communicators in systemic lupus erythematosus pathogenesis and its potential therapeutic significance","volume":"82","author":"Asgarzade","year":"2021","journal-title":"Hum. Immunol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109506_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.872","article-title":"Th17\/Treg balance is regulated by myeloid-derived suppressor cells in experimental autoimmune myocarditis","volume":"11","author":"Xiong","year":"2023","journal-title":"Immunity, Inflammation and Disease."},{"issue":"6\u20137","key":"10.1016\/j.thromres.2025.109506_bb0150","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/08820139.2012.673191","article-title":"Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship","volume":"41","author":"Monu","year":"2012","journal-title":"Immunol. Invest."},{"issue":"9","key":"10.1016\/j.thromres.2025.109506_bb0155","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.thromres.2025.109506_bb0160","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3389\/fimmu.2018.02499","article-title":"Reactive oxygen species as regulators of MDSC-mediated immune suppression","volume":"9","author":"Ohl","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.thromres.2025.109506_bb0165","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-17-0691","article-title":"Nitric oxide production by myeloid-derived suppressor cells plays a role in impairing fc receptor\u2013mediated natural killer cell function","volume":"24","author":"Stiff","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.thromres.2025.109506_bb0170","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.18632\/oncotarget.28303","article-title":"Myeloid-derived suppressor cells: cancer, autoimmune diseases, and more","volume":"13","author":"Shibata","year":"2022","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.thromres.2025.109506_bb0175","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3390\/ijms19051468","article-title":"Immunomodulatory function of myeloid-derived suppressor cells during B cell-mediated immune responses","volume":"19","author":"\u00d6zkan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-\u03b21","volume":"182","author":"Li","year":"2009","journal-title":"The Journal of Immunology."},{"issue":"7","key":"10.1016\/j.thromres.2025.109506_bb0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s12272-024-01504-2","article-title":"Dual roles of myeloid-derived suppressor cells in various diseases: a review","volume":"47","author":"Nepal","year":"2024","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.thromres.2025.109506_bb0190","series-title":"Platelets","first-page":"47","article-title":"The structure of resting and activated platelets","author":"Thomas","year":"2019"},{"issue":"12","key":"10.1016\/j.thromres.2025.109506_bb0195","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/jth.13147","article-title":"Platelet secretory behaviour: as diverse as the granules\u2026 or not?","volume":"13","author":"Heijnen","year":"2015","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2025.109506_bb0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09537100120068170","article-title":"The platelet release reaction: granules\u2019 constituents, secretion and functions","volume":"12","author":"Rendu","year":"2001","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2025.109506_bb0205","series-title":"Seminars in Thrombosis and Hemostasis","article-title":"Role of platelets in rheumatic chronic autoimmune inflammatory diseases","author":"P\u00e9\u010d","year":"2023"},{"issue":"12","key":"10.1016\/j.thromres.2025.109506_bb0210","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1111\/jcmm.13862","article-title":"The potential contribution and role of a blood platelets in autoimmune thyroid diseases","volume":"22","author":"Tomczy\u0144ska","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.thromres.2025.109506_bb0215","doi-asserted-by":"crossref","first-page":"354","DOI":"10.15537\/smj.2016.4.14768","article-title":"Pathogenic role of platelets in rheumatoid arthritis and systemic autoimmune diseases: perspectives and therapeutic aspects","volume":"37","author":"Harifi","year":"2016","journal-title":"Saudi Med. J."},{"issue":"6","key":"10.1016\/j.thromres.2025.109506_bb0220","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00296-018-4001-9","article-title":"From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders","volume":"38","author":"\u0141ukasik","year":"2018","journal-title":"Rheumatol. Int."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0225","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/art.39417","article-title":"Circulating apoptotic microparticles in systemic lupus erythematosus patients drive the activation of dendritic cell subsets and prime neutrophils for NETosis","volume":"68","author":"Dieker","year":"2016","journal-title":"Arthritis & Rheumatology."},{"issue":"5","key":"10.1016\/j.thromres.2025.109506_bb0230","first-page":"823","article-title":"Elevated levels of soluble CD40 ligand are associated with antiphospholipid antibodies in patients with systemic lupus erythematosus","volume":"35","author":"Kim","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109506_bb0235","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1111\/j.1538-7836.2005.01603.x","article-title":"Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity","volume":"3","author":"Barnard","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109506_bb0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fcvm.2019.00085","article-title":"Platelet-neutrophil interplay: insights into neutrophil extracellular trap (NET)-driven coagulation in infection","volume":"6","author":"Zucoloto","year":"2019","journal-title":"Frontiers in Cardiovascular Medicine."},{"issue":"7","key":"10.1016\/j.thromres.2025.109506_bb0245","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.3390\/ijms23073868","article-title":"Beyond hemostasis: platelet innate immune interactions and thromboinflammation","volume":"23","author":"Mandel","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.thromres.2025.109506_bb0250","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.exphem.2007.05.021","article-title":"Human platelets can activate peripheral blood B cells and increase production of immunoglobulins","volume":"35","author":"Cognasse","year":"2007","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2005.12.005","article-title":"The emerging role of platelets in adaptive immunity","volume":"238","author":"Elzey","year":"2005","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.thromres.2025.109506_bb0260","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fimmu.2018.00406","article-title":"Fresh evidence for platelets as neuronal and innate immune cells: their role in the activation, differentiation, and deactivation of Th1, Th17, and Tregs during tissue inflammation","volume":"9","author":"Ponomarev","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0265","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2009.11.008","article-title":"Transforming growth factor beta (TGF-\u03b2) and inflammation in cancer","volume":"21","author":"Bierie","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"13","key":"10.1016\/j.thromres.2025.109506_bb0270","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.7314\/APJCP.2014.15.13.5181","article-title":"Tumor-derived transforming growth factor-\u03b2 is critical for tumor progression and evasion from immune surveillance","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.thromres.2025.109506_bb0275","article-title":"Immune suppressive signaling regulated by latent transforming growth factor beta binding protein 1 promotes metastasis in cervical cancer","volume":"55","author":"Gu","year":"2023","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"9","key":"10.1016\/j.thromres.2025.109506_bb0280","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.thromres.2025.109506_bb0285","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/ijms19030869","article-title":"Characterization of multiple cytokine combinations and TGF-\u03b2 on differentiation and functions of myeloid-derived suppressor cells","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1_Supplement","key":"10.1016\/j.thromres.2025.109506_bb0290","doi-asserted-by":"crossref","first-page":"80.18","DOI":"10.4049\/jimmunol.198.Supp.80.18","article-title":"Myeloid derived suppressor cells are controlled by regulatory T cells via TGF-b during murine colitis","volume":"198","author":"Park","year":"2017","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.37349\/etat.2023.00137","article-title":"Transforming growth factor-\u03b2 signaling: from tumor microenvironment to anticancer therapy","volume":"4","author":"Chan","year":"2023","journal-title":"Exploration of targeted anti-tumor therapy."},{"key":"10.1016\/j.thromres.2025.109506_bb0300","article-title":"TGF-\u03b2 enhances immunosuppression of myeloid-derived suppressor cells to induce transplant immune tolerance through affecting Arg-1 expression","volume":"13","author":"Cao","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jcp.30529","article-title":"TGF-\u03b2 signaling: a recap of SMAD-independent and SMAD-dependent pathways","volume":"237","author":"Aashaq","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.thromres.2025.109506_bb0310","article-title":"Critical role of myeloid-derived suppressor cells in tumor-induced liver immune suppression through inhibition of NKT cell function","volume":"8","author":"Zhang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2025.109506_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01530","article-title":"Transcriptomic analyses of myeloid-derived suppressor cell subsets in the circulation of colorectal cancer patients","volume":"10","author":"Sasidharan Nair","year":"2020","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.thromres.2025.109506_bb0320","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1490853","article-title":"TGF-\u03b21 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy","volume":"7","author":"Jayaraman","year":"2018","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0325","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2088467","article-title":"Immune suppressive function of IL-1\u03b1 release in the tumor microenvironment regulated by calpain 1","volume":"11","author":"Lin","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.thromres.2025.109506_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fimmu.2013.00177","article-title":"Unique versus redundant functions of IL-1\u03b1 and IL-1\u03b2 in the tumor microenvironment","volume":"4","author":"Voronov","year":"2013","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0335","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ijc.23503","article-title":"Opposing effects of fibrosarcoma cell-derived IL-1\u03b1 and IL-1\u03b2 on immune response induction","volume":"123","author":"Marhaba","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.thromres.2025.109506_bb0340","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL-1\u03b2 regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2021.152165","article-title":"Interleukin-1beta triggers the expansion of circulating granulocytic myeloid-derived suppressor cell subset dependent on Erk1\/2 activation","volume":"227","author":"Shi","year":"2022","journal-title":"Immunobiology"},{"key":"10.1016\/j.thromres.2025.109506_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116491","article-title":"The tian-men-dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1\u03b2-mediated signalling in lung cancer","volume":"313","author":"Su","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.thromres.2025.109506_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661323","article-title":"Tumor NLRP3-derived IL-1\u03b2 drives the IL-6\/STAT3 axis resulting in sustained MDSC-mediated immunosuppression","volume":"12","author":"Tengesdal","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109506_bb0360","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1442167","article-title":"Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis","volume":"7","author":"Qin","year":"2018","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.thromres.2025.109506_bb0365","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/hep.30676","article-title":"Receptor-interacting protein kinase 3 deficiency recruits myeloid-derived suppressor cells to hepatocellular carcinoma through the chemokine (C-X-C motif) ligand 1\u2013chemokine (C-X-C motif) receptor 2 axis","volume":"70","author":"Li","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0370","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/s41467-018-03966-7","article-title":"Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation","volume":"9","author":"Taki","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.thromres.2025.109506_bb0375","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.3390\/ijms24087262","article-title":"Involvement in tumorigenesis and clinical significance of CXCL1 in reproductive cancers: breast cancer, cervical cancer, endometrial cancer, ovarian cancer and prostate cancer","volume":"24","author":"Korbecki","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.thromres.2025.109506_bb0380","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1111\/cas.13809","article-title":"Chemokine (C-X-C motif) ligand 1 and CXCL 2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells","volume":"109","author":"Shi","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.thromres.2025.109506_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216690","article-title":"Hyperactivation of \u03b2-catenin signal in hepatocellular carcinoma recruits myeloid-derived suppressor cells through PF4-CXCR3 axis","volume":"586","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"issue":"21","key":"10.1016\/j.thromres.2025.109506_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218412","article-title":"CC chemokines in a tumor: a review of pro-cancer and anti-cancer properties of the ligands of receptors CCR1, CCR2, CCR3, and CCR4","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0395","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/08923973.2017.1417997","article-title":"Blockade of CCR5-mediated myeloid derived suppressor cell accumulation enhances anti-PD1 efficacy in gastric cancer","volume":"40","author":"Yang","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"6","key":"10.1016\/j.thromres.2025.109506_bb0400","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/CJI.0b013e3182619c8e","article-title":"TIMP-2 targets tumor-associated myeloid suppressor cells with effects in cancer immune dysfunction and angiogenesis","volume":"35","author":"Guedez","year":"2012","journal-title":"J. Immunother."},{"issue":"4","key":"10.1016\/j.thromres.2025.109506_bb0405","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.rbmo.2019.05.014","article-title":"CCR5\/CCR5 ligand-induced myeloid-derived suppressor cells are related to the progression of endometriosis","volume":"39","author":"Guo","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.thromres.2025.109506_bb0410","article-title":"Myeloid-derived suppressor cells alleviate renal fibrosis progression via regulation of CCL5-CCR5 axis","volume":"12","author":"Qiu","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2025.109506_bb0415","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41388-019-1084-z","article-title":"Periodontal inflammation recruits distant metastatic breast cancer cells by increasing myeloid-derived suppressor cells","volume":"39","author":"Cheng","year":"2020","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.thromres.2025.109506_bb0420","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/bjh.19049","article-title":"Tumour-derived exosomes promote the induction of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells by delivering miR-106a-5p and miR-146a-5p in multiple myeloma","volume":"203","author":"Mizuhara","year":"2023","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.thromres.2025.109506_bb0425","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","article-title":"Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells","volume":"67","author":"Sinha","year":"2007","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.thromres.2025.109506_bb0430","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.24249","article-title":"Induction of myeloid-derived suppressor cells by tumor exosomes","volume":"124","author":"Xiang","year":"2009","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.thromres.2025.109506_bb0435","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1182\/blood-2011-07-365825","article-title":"Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells","volume":"118","author":"Obermajer","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2025.109506_bb0440","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4161\/onci.19681","article-title":"Key role of the positive feedback between PGE2 and COX2 in the biology of myeloid-derived suppressor cells","volume":"1","author":"Obermajer","year":"2012","journal-title":"Oncoimmunology"},{"issue":"6\u20137","key":"10.1016\/j.thromres.2025.109506_bb0445","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/08820139.2012.695417","article-title":"PGE2-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells","volume":"41","author":"Obermajer","year":"2012","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.thromres.2025.109506_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355769","article-title":"EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells","volume":"15","author":"Cuenca-Escalona","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0455","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1158\/2326-6066.CIR-15-0070-T","article-title":"MIF is necessary for late-stage melanoma patient MDSC immune suppression and differentiation","volume":"4","author":"Yaddanapudi","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.thromres.2025.109506_bb0460","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.940554","article-title":"Dynamic changes in myeloid-derived suppressor cells during the menstrual cycle: a pilot study","volume":"9","author":"Xu","year":"2022","journal-title":"Front. Med."},{"issue":"19","key":"10.1016\/j.thromres.2025.109506_bb0465","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1158\/0008-5472.CAN-17-3962","article-title":"A RIPK3-PGE2 circuit mediates myeloid-derived suppressor cell\u2013potentiated colorectal carcinogenesis","volume":"78","author":"Yan","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0470","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.celrep.2017.09.018","article-title":"Prostaglandin E2 leads to the acquisition of DNMT3A-dependent tolerogenic functions in human myeloid-derived suppressor cells","volume":"21","author":"Rodr\u00edguez-Ubreva","year":"2017","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0475","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-06-2197","article-title":"Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma","volume":"13","author":"Ochoa","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.thromres.2025.109506_bb0480","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-12-4115","article-title":"Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2\u2013dependent mechanisms","volume":"73","author":"Mao","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.thromres.2025.109506_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588500","article-title":"Granulocytic myeloid-derived suppressor cell exosomal prostaglandin E2 ameliorates collagen-induced arthritis by enhancing IL-10+ B cells","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.thromres.2025.109506_bb0490","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/0008-5472.CAN-19-2843","article-title":"Tumor-derived prostaglandin E2 promotes p50 NF-\u03baB-dependent differentiation of monocytic MDSCs","volume":"80","author":"Porta","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.thromres.2025.109506_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00475","article-title":"Prostaglanin-E2 potentiates the suppressive functions of human mononuclear myeloid-derived suppressor cells and increases their capacity to expand IL-10-producing regulatory T cell subsets","volume":"10","author":"Tomi\u0107","year":"2019","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109506_bb0500","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CM9.0000000000001234","article-title":"Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma","volume":"134","author":"Xu","year":"2021","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0505","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1189\/jlb.5A1113-626RR","article-title":"Dopamine inhibits the function of Gr-1+ CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity","volume":"97","author":"Wu","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0510","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1189\/jlb.5A1213-644R","article-title":"Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells","volume":"96","author":"Martin","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.thromres.2025.109506_bb0515","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.18632\/oncotarget.7211","article-title":"The impact of ranitidine on monocyte responses in the context of solid tumors","volume":"7","author":"Vila-Leahey","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0520","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00262-018-2253-6","article-title":"Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1\/PD-L1 checkpoint blockade","volume":"68","author":"Grauers Wiktorin","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-47096-9","article-title":"Myeloid-derived suppressor cell mitochondrial fitness governs chemotherapeutic efficacy in hematologic malignancies","volume":"15","author":"Daneshmandi","year":"2024","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.thromres.2025.109506_bb0530","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.109","article-title":"ATP\/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment","volume":"5","author":"Bianchi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"19","key":"10.1016\/j.thromres.2025.109506_bb0535","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1182\/blood.2019001950","article-title":"Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD","volume":"134","author":"Koehn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109506_bb0540","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2019.02.010","article-title":"The role of the P2X7 receptor in myeloid-derived suppressor cells and immunosuppression","volume":"47","author":"Principi","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"issue":"26","key":"10.1016\/j.thromres.2025.109506_bb0545","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1182\/blood.2022016029","article-title":"Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia","volume":"140","author":"Ni","year":"2022","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0550","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165637","article-title":"Circulating myeloid-derived suppressor cells predict disease activity and treatment response in patients with immune thrombocytopenia","volume":"50","author":"Zhou","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"7","key":"10.1016\/j.thromres.2025.109506_bb0555","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41423-022-00859-0","article-title":"Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia","volume":"19","author":"Hou","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.thromres.2025.109506_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2020.102529","article-title":"Myeloid-derived suppressor cells anticipate sustained treatment response in newly-diagnosed and persistent primary immune thrombocytopenia","volume":"87","author":"Elsaied","year":"2021","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.thromres.2025.109506_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1424-8","article-title":"Distinct alterations of CD68+ CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment","volume":"16","author":"Shao","year":"2018","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0570","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.12302","article-title":"Tumor necrosis factor receptor-associated factor 6 (TRAF 6) regulation of development, function, and homeostasis of the immune system","volume":"266","author":"Walsh","year":"2015","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.thromres.2025.109506_bb0575","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood-2015-10-674531","article-title":"High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia","volume":"127","author":"Hou","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109506_bb0580","first-page":"1","article-title":"Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP","author":"Zhu","year":"2024","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0585","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1080\/16078454.2022.2151230","article-title":"Progress on the efficacy and potential mechanisms of rapamycin in the treatment of immune thrombocytopenia","volume":"27","author":"Wang","year":"2022","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.thromres.2025.109506_bb0590","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2217\/bmm-2018-0236","article-title":"A biomarker and therapeutical target in immune thrombocytopenia: TNF receptor-associated factor 6","volume":"13","author":"Asoglu","year":"2019","journal-title":"Biomark. Med."},{"issue":"2","key":"10.1016\/j.thromres.2025.109506_bb0595","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14542","article-title":"Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells","volume":"181","author":"Aslam","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2025.109506_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.00110","article-title":"Sirolimus as rescue therapy for refractory\/relapsed immune thrombocytopenia: results of a single-center, prospective, single-arm study","volume":"7","author":"Feng","year":"2020","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.thromres.2025.109506_bb0605","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.celrep.2019.05.020","article-title":"Activation of mevalonate pathway via LKB1 is essential for stability of Treg cells","volume":"27","author":"Timilshina","year":"2019","journal-title":"Cell Rep."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:41:57Z","timestamp":1781019717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":121,"alternative-id":["S0049384825002567"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109506","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of platelets in the regulation of myeloid-derived suppressor cells in immune thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109506"}}